Industries > Pharma > In-Vitro Fertilization (IVF) Market Report 2019-2029

In-Vitro Fertilization (IVF) Market Report 2019-2029

Forecasts by Instrument (Culture Media, Disposable Devices, Capital Equipment), by Treatment (Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen donor), by Application (Fertility Clinics, Hospitals, Others) Plus Analysis of Leading Companies

PAGES: 144
PRODUCT CODE: PHA0636
SUBMARKET:

DOWNLOAD FREE SAMPLE
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0636 Category: Tag:

The comprehensive report offers market estimation and forecast for the period ranging 2019 – 2029 for leading national markets and rest of the world. Moreover, the report contains dedicated leading companies such as OVASCIENCE, INC., VITROLIFE, EMD SERONO, INC., IRVINE SCIENTIFIC, THE COOPER COMPANIES, INC., COOK MEDICAL, THERMO FISHER SCIENTIFIC, INC., GENEA BIOMEDX, PROGYNY, INC., BOSTON IVF, ORIGIO, FERRING PHARMACEUTICAL, BAYER AG, And ORGANON.

In-Vitro Fertilization (IVF) Market Report 2019-2029, By Instrument
– Culture Media
– Disposable Devices
– Capital Equipment

In-Vitro Fertilization (IVF) Market Report 2019-2029, By Treatment
– Fresh Nondonor
– Frozen Nondonor
– Fresh Donor
– Frozen donor

In-Vitro Fertilization (IVF) Market Report 2019-2029, By Application
– Fertility Clinics
– Hospitals
– Others

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for In-Vitro Fertilization (IVF) Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for In-Vitro Fertilization (IVF) Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ